Leendert H. J. Looijenga
Cell · 2003–2018
A researcher in the Science corpus: 10 papers; trusts 0 researchers and is trusted by 0 researchers here, as inferred from the citation graph.
Whom Leendert H. J. Looijenga trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
Papers from Leendert H. J. Looijenga's perspective
Ordered by how strongly the researchers Leendert H. J. Looijenga trusts endorse each paper. Same corpus, a different order for every researcher.
- Specificity of microRNA target selection in translational repression. (Genes & Development)
- Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells (Nature Genetics)
- Prediction of mammalian microRNA targets. (Cell)
- A System for Stable Expression of Short Interfering RNAs in Mammalian Cells (Science)
- MicroRNA expression profiles classify human cancers (Nature)
- MicroRNAs Modulate Hematopoietic Lineage Differentiation (Science)
- RAS is regulated by the let-7 microRNA family. (Cell)
- Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets.
- A microRNA polycistron as a potential human oncogene (Nature)
- Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma. (Cancer Research)
Their papers
- A genetic screen implicates miRNA-372 and miRNA-373 as oncogenes in testicular germ cell tumors. (2006) — 1,287 citations
- Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients (2018) — 792 citations
- Comprehensive Characterization of Cancer Driver Genes and Mutations (2018) — 2,007 citations
- Testicular germ-cell tumours in a broader perspective (2005) — 889 citations
- Pathogenic germline variants in 10,389 adult cancers (2018) — 734 citations
- The Immune Landscape of Cancer (2018) — 4,752 citations
- Oncogenic Signaling Pathways in The Cancer Genome Atlas (2018) — 2,663 citations
- WHO Classification of of Tumours of the Urinary System and Male Genital Organs (2016) — 1,029 citations
- National Academy of Clinical Biochemistry laboratory medicine practice guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers. (2008) — 658 citations
- POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. (2003) — 662 citations